Denis Dufrane, MD, PhD

Co-Founder, Chief Executive Officer and Board Member

Denis co-founded Novadip in 2013 and joined the company as Chief Scientific Officer in 2015 before being appointed CEO. Prior to joining Novadip on a full-time basis, Pr. Dufrane was head of both the Musculoskeletal Tissue Bank and the Tissue/Cells Therapy Centre at St. Luc University Hospital, Brussels, Belgium. Before that, he had been head of the Endocrine Cell Therapy Unit.      Dr. Dufrane has been a member of the Belgium Superior Health Council since 2014. He has published more than 50 manuscripts in peer-reviewed journals, presented 40 lectures, and has more than 150 communications with more than 3.800 citations. He is a reviewer and member of the editorial boards of a number of  scientific and medical peer-reviewed journals and has received numerous scientific awards. Dr. Dufrane received his medical degree and his doctorate in biomedical sciences (orientation: cell therapy) from the Université Catholique de Louvain, Belgium.